Is Jupiter Neurosciences, Stock a Good Investment?
Jupiter Neurosciences, Investment Advice | JUNS |
- Examine Jupiter Neurosciences,'s financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Jupiter Neurosciences,'s leadership team and their track record. Good management can help Jupiter Neurosciences, navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Pharmaceutical Products space and any emerging trends that could impact Jupiter Neurosciences,'s business and its evolving consumer preferences.
- Compare Jupiter Neurosciences,'s performance and market position to its competitors. Analyze how Jupiter Neurosciences, is positioned in terms of product offerings, innovation, and market share.
- Check if Jupiter Neurosciences, pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Jupiter Neurosciences,'s stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Jupiter Neurosciences, Common stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Jupiter Neurosciences, Common is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Solid | Details | |
Volatility | Very risky | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Moves completely opposite to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Jupiter Neurosciences, Stock
Researching Jupiter Neurosciences,'s stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). The company had not issued any dividends in recent years.
To determine if Jupiter Neurosciences, is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Jupiter Neurosciences,'s research are outlined below:
| Jupiter Neurosciences, is way too risky over 90 days horizon | |
| Jupiter Neurosciences, appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (4.78 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Jupiter Neurosciences, generates negative cash flow from operations | |
| Jupiter Neurosciences, has a poor financial position based on the latest SEC disclosures | |
| Latest headline from investing.com: Jupiter Neurosciences inks deal for Southeast Asia expansion |
Jupiter Neurosciences,'s market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 200.22 M.Market Cap |
|
Jupiter Neurosciences,'s profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (32.19) | (33.80) | |
| Return On Capital Employed | 0.69 | 0.46 | |
| Return On Assets | (32.19) | (33.80) | |
| Return On Equity | 0.82 | 0.54 |
Determining Jupiter Neurosciences,'s profitability involves analyzing its financial statements and using various financial metrics to determine if Jupiter Neurosciences, is a good buy. For example, gross profit margin measures Jupiter Neurosciences,'s profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Jupiter Neurosciences,'s profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Jupiter Neurosciences,'s accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Jupiter Neurosciences, Common. Check Jupiter Neurosciences,'s Beneish M Score to see the likelihood of Jupiter Neurosciences,'s management manipulating its earnings.
Basic technical analysis of Jupiter Stock
As of the 23rd of December, Jupiter Neurosciences, retains the Risk Adjusted Performance of 0.269, standard deviation of 16.33, and Market Risk Adjusted Performance of (2.27). Jupiter Neurosciences, technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Jupiter Neurosciences, information ratio and kurtosis to decide if Jupiter Neurosciences, is priced fairly, providing market reflects its last-minute price of 9.73 per share. Given that Jupiter Neurosciences, Common has information ratio of 0.3256, we strongly advise you to confirm Jupiter Neurosciences,'s regular market performance to make sure the company can sustain itself at a future point.Understand Jupiter Neurosciences,'s technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Jupiter Neurosciences,'s various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.269 | |||
| Market Risk Adjusted Performance | (2.27) | |||
| Mean Deviation | 13.48 | |||
| Coefficient Of Variation | 305.26 | |||
| Standard Deviation | 16.33 | |||
| Variance | 266.71 | |||
| Information Ratio | 0.3256 | |||
| Jensen Alpha | 5.39 | |||
| Total Risk Alpha | 4.88 | |||
| Treynor Ratio | (2.28) | |||
| Maximum Drawdown | 54.21 | |||
| Value At Risk | (20.56) | |||
| Potential Upside | 33.65 | |||
| Skewness | 0.1709 | |||
| Kurtosis | (0.85) |
| Risk Adjusted Performance | 0.269 | |||
| Market Risk Adjusted Performance | (2.27) | |||
| Mean Deviation | 13.48 | |||
| Coefficient Of Variation | 305.26 | |||
| Standard Deviation | 16.33 | |||
| Variance | 266.71 | |||
| Information Ratio | 0.3256 | |||
| Jensen Alpha | 5.39 | |||
| Total Risk Alpha | 4.88 | |||
| Treynor Ratio | (2.28) | |||
| Maximum Drawdown | 54.21 | |||
| Value At Risk | (20.56) | |||
| Potential Upside | 33.65 | |||
| Skewness | 0.1709 | |||
| Kurtosis | (0.85) |
Consider Jupiter Neurosciences,'s intraday indicators
Jupiter Neurosciences, intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Jupiter Neurosciences, stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Jupiter Neurosciences, Corporate Filings
8K | 20th of December 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 2nd of December 2024 Certification of the accuracy of the financial statements and disclosures | ViewVerify | |
F3 | 15th of November 2024 The schedule filed by any person or group who acquires beneficial ownership of more than 5% of a voting class of a company's equity securities registered under Section 12 of the Act | ViewVerify |
F3 | 13th of November 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
Jupiter Stock media impact
Far too much social signal, news, headlines, and media speculation about Jupiter Neurosciences, that are available to investors today. That information is available publicly through Jupiter media outlets and privately through word of mouth or via Jupiter internal channels. However, regardless of the origin, that massive amount of Jupiter data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Jupiter Neurosciences, news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Jupiter Neurosciences, relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Jupiter Neurosciences,'s headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Jupiter Neurosciences, alpha.
Jupiter Neurosciences, Corporate Executives
Elected by the shareholders, the Jupiter Neurosciences,'s board of directors comprises two types of representatives: Jupiter Neurosciences, inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Jupiter. The board's role is to monitor Jupiter Neurosciences,'s management team and ensure that shareholders' interests are well served. Jupiter Neurosciences,'s inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Jupiter Neurosciences,'s outside directors are responsible for providing unbiased perspectives on the board's policies.
| Marshall Hayward | Chief CoFounder | Profile | |
| Shaun Brothers | Consulting CoFounder | Profile | |
| Alexander Rosen | CoFounder Officer | Profile | |
| Saleem CPA | CFO Secretary | Profile |
Additional Tools for Jupiter Stock Analysis
When running Jupiter Neurosciences,'s price analysis, check to measure Jupiter Neurosciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jupiter Neurosciences, is operating at the current time. Most of Jupiter Neurosciences,'s value examination focuses on studying past and present price action to predict the probability of Jupiter Neurosciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jupiter Neurosciences,'s price. Additionally, you may evaluate how the addition of Jupiter Neurosciences, to your portfolios can decrease your overall portfolio volatility.